First Time Loading...

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 113.44 USD -0.04%
Updated: Mar 28, 2024

Abbott Laboratories
Cash Equivalents

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
|

Abbott Laboratories
Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$6.9B
CAGR 3-Years
0%
CAGR 5-Years
12%
CAGR 10-Years
7%
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$1.2B
CAGR 3-Years
-29%
CAGR 5-Years
5%
CAGR 10-Years
-3%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$865m
CAGR 3-Years
-21%
CAGR 5-Years
43%
CAGR 10-Years
15%
Edwards Lifesciences Corp
NYSE:EW
Cash Equivalents
$1.1B
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Cash Equivalents
$2.9B
CAGR 3-Years
0%
CAGR 5-Years
-4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$2.2B
CAGR 3-Years
31%
CAGR 5-Years
30%
CAGR 10-Years
11%

See Also

What is Abbott Laboratories's Cash Equivalents?
Cash Equivalents
6.9B USD

Based on the financial report for Dec 31, 2023, Abbott Laboratories's Cash Equivalents amounts to 6.9B USD.

What is Abbott Laboratories's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
7%

Over the last year, the Cash Equivalents growth was -30%.